These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3416910)

  • 1. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.
    Blackburn TP; Thornber CW; Pearce RJ; Cox B
    Eur J Pharmacol; 1988 Jun; 150(3):247-56. PubMed ID: 3416910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological comparison of the receptors mediating contractile responses to 5-hydroxytryptamine in the rat isolated caudal artery and fundic strip.
    Growcott JW; Cox B; Blackburn TP
    J Pharm Pharmacol; 1993 Oct; 45(10):876-81. PubMed ID: 7904626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
    Jansen I; Blackburn T; Eriksen K; Edvinsson L
    Pharmacol Toxicol; 1991 Jan; 68(1):8-13. PubMed ID: 2008418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist.
    Chairungsrilerd N; Furukawa KI; Ohta T; Nozoe S; Ohizumi Y
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):25-31. PubMed ID: 9459569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig.
    Chang JY; Hardebo JE; Owman C
    Acta Physiol Scand; 1988 Jan; 132(1):91-102. PubMed ID: 2906211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist.
    Blackburn TP; Cox B; Thornber CW; Pearce RJ
    Eur J Pharmacol; 1990 May; 180(2-3):229-37. PubMed ID: 2163866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on serotonin (5-HT)3-receptor antagonist effects of enantiomers of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Kamato T; Ito H; Suzuki T; Miyata K; Honda K
    Jpn J Pharmacol; 1995 Mar; 67(3):185-94. PubMed ID: 7630036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
    Sanger GJ
    Br J Pharmacol; 1987 May; 91(1):77-87. PubMed ID: 3594084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.
    Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB
    Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
    Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skimmianine and related furoquinolines function as antagonists of 5-hydroxytryptamine receptors in animals.
    Cheng JT; Chang TK; Chen IS
    J Auton Pharmacol; 1994 Oct; 14(5):365-74. PubMed ID: 7829541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
    Craig DA; Clarke DE
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1378-86. PubMed ID: 2319473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
    Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
    Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle.
    Baxter GS; Murphy OE; Blackburn TP
    Br J Pharmacol; 1994 May; 112(1):323-31. PubMed ID: 8032658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.